Symptom burden and quality of life in patients with pancreatic and peri-pancreatic cancer at admission to specialized palliative care: a nationwide register-based study in Denmark
摘要
Most patients with pancreatic cancer have advanced disease at the time of diagnosis and a poor prognosis. Therefore, it is important to investigate the symptom burden for these patients, e.g., at the start of specialized palliative care (SPC).
AimTo investigate symptoms, problems, and quality of life in patients with pancreatic cancer at the start of SPC and to explore the associations with demographic factors.
MethodThe data sources were the national Danish Palliative Care Database and Danish Pancreatic Cancer Database. Patients with pancreatic and peri-pancreatic cancer, who were diagnosed and died between 2011 and 2018 and admitted to SPC were included. Data about symptoms, problems, and quality of life were collected by EORTC QLQ-C15-PAL (10 scales ranging 0–100). Using ordinal logistic regression analyses, the associations between demographic factors and the symptoms and functions scores and QOL (outcomes) were investigated.
ResultsFrom 2011–18, 3,497 patients with pancreatic cancer were admitted to SPC and 58% (N = 2028) of these completed the QLQ-C15-PAL. Patients with pancreatic cancer had a high symptom burden regarding fatigue (mean: 76), loss of appetite (mean: 68), and pain (mean: 56), whereas among function scales, low physical function (mean: 35) and low quality of life (mean: 39) were found. Younger patients and patients who had not received any anticancer treatment had a higher symptom burden.
ConclusionIn this nationally representative study, patients with pancreatic cancer had a high symptom burden and low quality of life at admission to SPC, underlining the need for symptom assessment and palliative care, also before referral to SPC.